Skip to main content
Premium Trial:

Request an Annual Quote

AmoyDx NSCLC Circulating DNA Extraction System

AmoyDx of China, through its German distributor MoBiTec, has launched a system for extracting circulating DNA from non-small cell lung cancer patients. Circulating cell-free DNA is an important emerging biomarker in cancer diagnostics, said AmoyDx in a statement, as well as a non-invasive diagnostic solution for a wide range of clinical disorders. The kit is specially designed for effective isolation and purification of DNA from peripheral blood (serum or plasma) and pleural effusion. The purified DNA is suitable for downstream applications such as real-time quantitative PCR, said AmoyDx in a statement.  

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.